{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T05:05:01Z","timestamp":1779512701818,"version":"3.53.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372099"],"award-info":[{"award-number":["82372099"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M741390"],"award-info":[{"award-number":["2023M741390"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010226","name":"Guangdong Province Department of Education","doi-asserted-by":"publisher","award":["2024ZDZX2044"],"award-info":[{"award-number":["2024ZDZX2044"]}],"id":[{"id":"10.13039\/501100010226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010226","name":"Guangdong Province Department of Education","doi-asserted-by":"publisher","award":["2022KTSCX029"],"award-info":[{"award-number":["2022KTSCX029"]}],"id":[{"id":"10.13039\/501100010226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.cbi.2026.112019","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T07:29:13Z","timestamp":1773041353000},"page":"112019","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A novel PDE4A inhibitor suppresses hepatocellular carcinoma progression through activating the cAMP-induced PKA pathway"],"prefix":"10.1016","volume":"432","author":[{"given":"Zhiting","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqing","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuran","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minfeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6130-7266","authenticated-orcid":false,"given":"Jianfu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cbi.2026.112019_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.cbi.2026.112019_bib2","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/s12951-022-01615-2","article-title":"Emerging nanobiotechnology for precise theranostics of hepatocellular carcinoma","volume":"20","author":"Xu","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"10127","key":"10.1016\/j.cbi.2026.112019_bib3","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet (London, England)"},{"issue":"1","key":"10.1016\/j.cbi.2026.112019_bib4","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1186\/s13046-019-1412-8","article-title":"Molecular targeted and immune checkpoint therapy for advanced hepatocellular carcinoma","volume":"38","author":"Liu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res. : CR"},{"issue":"20","key":"10.1016\/j.cbi.2026.112019_bib5","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.cbi.2026.112019_bib6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/ot9.0000000000000093","article-title":"Novel perspectives on combining immune checkpoint inhibitors and antiangiogenic drugs for advanced hepatocellular carcinoma","volume":"11","author":"Peng","year":"2025","journal-title":"Oncol. Trans. Med."},{"issue":"3","key":"10.1016\/j.cbi.2026.112019_bib7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/01.RES.0000256354.95791.f1","article-title":"Overview of PDEs and their regulation","volume":"100","author":"Omori","year":"2007","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.cbi.2026.112019_bib8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3892\/etm.2012.587","article-title":"Phosphodiesterase 4 regulates the migration of B16-F10 melanoma cells","volume":"4","author":"Watanabe","year":"2012","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.cbi.2026.112019_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.982130","article-title":"The regulatory role of PDE4B in the progression of inflammatory function study","volume":"13","author":"Su","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"15","key":"10.1016\/j.cbi.2026.112019_bib10","doi-asserted-by":"crossref","first-page":"6109","DOI":"10.1073\/pnas.1218206110","article-title":"Genomic and functional characterizations of phosphodiesterase subtype 4D in human cancers","volume":"110","author":"Lin","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.cbi.2026.112019_bib11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40164-020-00191-1","article-title":"Complex roles of cAMP-PKA-CREB signaling in cancer","volume":"9","author":"Zhang","year":"2020","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.cbi.2026.112019_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114431","article-title":"PDE4 inhibition as a therapeutic strategy for improvement of pulmonary dysfunctions in Covid-19 and cigarette smoking","volume":"185","author":"Lugnier","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2026.112019_bib13","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1471-2121-11-92","article-title":"cAMP\/PKA signaling balances respiratory activity with mitochondria dependent apoptosis via transcriptional regulation","volume":"11","author":"Leadsham","year":"2010","journal-title":"BMC Cell Biol."},{"issue":"2","key":"10.1016\/j.cbi.2026.112019_bib14","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.celrep.2012.12.021","article-title":"Fungicidal drugs induce a common oxidative-damage cellular death pathway","volume":"3","author":"Belenky","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.cbi.2026.112019_bib15","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3389\/fimmu.2018.00920","volume":"9","author":"Lee","year":"2018","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.cbi.2026.112019_bib16","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.3892\/ol.2014.2422","article-title":"Knockdown of phosphodiesterase 4D inhibits nasopharyngeal carcinoma proliferation via the epidermal growth factor receptor signaling pathway","volume":"8","author":"Xu","year":"2014","journal-title":"Oncol. Lett."},{"issue":"46","key":"10.1016\/j.cbi.2026.112019_bib17","doi-asserted-by":"crossref","first-page":"43623","DOI":"10.1074\/jbc.M203926200","article-title":"Cyclic AMP induces transactivation of the receptors for epidermal growth factor and nerve growth factor, thereby modulating activation of MAP kinase, Akt, and neurite outgrowth in PC12 cells","volume":"277","author":"Piiper","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.cbi.2026.112019_bib18","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1210\/me.2010-0410","article-title":"GPCR\/EGFR cross talk is conserved in gonadal and adrenal steroidogenesis but is uniquely regulated by matrix metalloproteinases 2 and 9 in the ovary","volume":"25","author":"Carbajal","year":"2011","journal-title":"Mol. Endocrinol."},{"issue":"18","key":"10.1016\/j.cbi.2026.112019_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810616","article-title":"The complexity and multiplicity of the specific cAMP phosphodiesterase family: PDE4, open new adapted therapeutic approaches","volume":"23","author":"Lugnier","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"23","key":"10.1016\/j.cbi.2026.112019_bib20","doi-asserted-by":"crossref","first-page":"7717","DOI":"10.1158\/1078-0432.CCR-08-0827","article-title":"Targeted inhibition of cyclic AMP phosphodiesterase-4 promotes brain tumor regression","volume":"14","author":"Goldhoff","year":"2008","journal-title":"Clin. Cancer Res. : Off. J. Am. Assoc. Cancer Resn"},{"issue":"7","key":"10.1016\/j.cbi.2026.112019_bib21","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1023\/A:1011926116777","article-title":"Cyclic AMP specific phosphodiesterase activity and colon cancer cell motility","volume":"18","author":"Murata","year":"2000","journal-title":"Clin. Exp. Metastasis"},{"issue":"7","key":"10.1016\/j.cbi.2026.112019_bib22","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1182\/blood.V92.7.2484","article-title":"Type 4 cyclic adenosine monophosphate phosphodiesterase as a therapeutic target in chronic lymphocytic leukemia","volume":"92","author":"Kim","year":"1998","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.cbi.2026.112019_bib23","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1182\/blood.V99.9.3390","article-title":"Inhibition of PDE4 phosphodiesterase activity induces growth suppression, apoptosis, glucocorticoid sensitivity, p53, and p21(WAF1\/CIP1) proteins in human acute lymphoblastic leukemia cells","volume":"99","author":"Ogawa","year":"2002","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.cbi.2026.112019_bib24","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1002\/jcb.25798","article-title":"Increase of intracellular cyclic AMP by PDE4 inhibitors affects HepG2 cell cycle progression and survival","volume":"118","author":"Massimi","year":"2017","journal-title":"J. Cell. Biochem."},{"issue":"15","key":"10.1016\/j.cbi.2026.112019_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27154964","article-title":"An overview of PDE4 inhibitors in clinical trials: 2010 to early 2022","volume":"27","author":"Crocetti","year":"2022","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.cbi.2026.112019_bib26","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1080\/14656566.2019.1604688","article-title":"Evaluating crisaborole as a treatment option for atopic dermatitis","volume":"20","author":"Ramachandran","year":"2019","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.cbi.2026.112019_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1021537","article-title":"Efficacy and safety profile of phosphodiesterase 4 inhibitor in the treatment of psoriasis: a systematic review and meta-analysis of randomized controlled trials","volume":"13","author":"Kang","year":"2022","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.cbi.2026.112019_bib28","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1136\/thx.2006.075937","article-title":"Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD","volume":"62","author":"Grootendorst","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.cbi.2026.112019_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121715","article-title":"Periplocin inhibits hepatocellular carcinoma progression and reduces the recruitment of MDSCs through AKT\/NF-\u03baB pathway","volume":"324","author":"Lin","year":"2023","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.cbi.2026.112019_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006381","article-title":"Zoledronic acid and thymosin \u03b11 elicit antitumor immunity against prostate cancer by enhancing tumor inflammation and cytotoxic T cells","volume":"11","author":"Wang","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"6","key":"10.1016\/j.cbi.2026.112019_bib31","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1021\/acs.jmedchem.0c00060","article-title":"Discovery and optimization of \u03b1-Mangostin derivatives as novel PDE4 inhibitors for the treatment of vascular dementia","volume":"63","author":"Liang","year":"2020","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.cbi.2026.112019_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.108239","article-title":"PDE4 inhibitor rolipram represses hedgehog signaling via ubiquitin-mediated proteolysis of GLI transcription factors to regress breast cancer","volume":"301","author":"Bagchi","year":"2025","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2026.112019_bib33","article-title":"BMS-470539 Attenuates oxidative stress and neuronal apoptosis via MC1R\/cAMP\/PKA\/Nurr1 signaling pathway in a neonatal hypoxic-ischemic rat model","volume":"2022","author":"Yu","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"8","key":"10.1016\/j.cbi.2026.112019_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15082130","article-title":"Targeting EGFR\/PI3K\/AKT\/mTOR signaling in hepatocellular carcinoma","volume":"15","author":"Bang","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.cbi.2026.112019_bib35","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3389\/fcell.2020.00478","article-title":"Increased expression of Fibulin-1 is associated with hepatocellular carcinoma progression by regulating the notch signaling pathway","volume":"8","author":"Gong","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.cbi.2026.112019_bib36","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/ot9.0000000000000086","article-title":"Comprehensive insights into systemic therapy for the whole-course management of hepatocellular carcinoma","volume":"11","author":"Jiang","year":"2025","journal-title":"Oncol. Trans. Med."},{"issue":"9","key":"10.1016\/j.cbi.2026.112019_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13092182","article-title":"Phosphodiesterase 4D depletion\/inhibition exerts anti-oncogenic properties in hepatocellular carcinoma","volume":"13","author":"Ragusa","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.cbi.2026.112019_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215749","article-title":"PDE4D binds and interacts with YAP to cooperatively promote HCC progression","volume":"541","author":"Ren","year":"2022","journal-title":"Cancer Lett."},{"issue":"626","key":"10.1016\/j.cbi.2026.112019_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf3917","article-title":"Glioblastoma stem cells reprogram chromatin in vivo to generate selective therapeutic dependencies on DPY30 and phosphodiesterases","volume":"14","author":"Dixit","year":"2022","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.cbi.2026.112019_bib40","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.bbrc.2018.12.004","article-title":"Phosphodiesterase 4B is an effective therapeutic target in colorectal cancer","volume":"508","author":"Kim","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.cbi.2026.112019_bib41","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/onc.2012.136","article-title":"Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF","volume":"32","author":"Pullamsetti","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.cbi.2026.112019_bib42","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.3389\/fphar.2020.01266","article-title":"Rousseau E: NCS 613, a potent PDE4 inhibitor, displays anti-inflammatory and anti-proliferative properties on A549 lung epithelial cells and human lung adenocarcinoma explants","volume":"11","author":"Yougbare","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.cbi.2026.112019_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090627","article-title":"Phosphodiesterase 3\/4 inhibitor zardaverine exhibits potent and selective antitumor activity against hepatocellular carcinoma both in vitro and in vivo independently of phosphodiesterase inhibition","volume":"9","author":"Sun","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.cbi.2026.112019_bib44","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/leu.2015.302","article-title":"A phosphodiesterase 4B-dependent interplay between tumor cells and the microenvironment regulates angiogenesis in B-cell lymphoma","volume":"30","author":"Suhasini","year":"2016","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.cbi.2026.112019_bib45","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/35070000","article-title":"Phosphorylation of Snapin by PKA modulates its interaction with the SNARE complex","volume":"3","author":"Chheda","year":"2001","journal-title":"Nat. Cell Biol."},{"issue":"4","key":"10.1016\/j.cbi.2026.112019_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/cells8040287","article-title":"Mitochondrial biogenesis and mitochondrial reactive oxygen species (ROS): a complex relationship regulated by the cAMP\/PKA signaling pathway","volume":"8","author":"Bouchez","year":"2019","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.cbi.2026.112019_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/cells14110793","article-title":"Protein kinase A regulates the cell cycle to affect the induction rate in the parthenogenetic reproduction of the silkworm, Bombyx mori","volume":"14","author":"Xu","year":"2025","journal-title":"Cells"},{"issue":"22","key":"10.1016\/j.cbi.2026.112019_bib48","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1042\/BCJ20230352","article-title":"Protein kinase A and local signaling in cancer","volume":"481","author":"Rosenthal","year":"2024","journal-title":"Biochem. J."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279726001274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279726001274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T04:14:00Z","timestamp":1779509640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279726001274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":48,"alternative-id":["S0009279726001274"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2026.112019","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel PDE4A inhibitor suppresses hepatocellular carcinoma progression through activating the cAMP-induced PKA pathway","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2026.112019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112019"}}